Mandate

Vinge advises TA Associates together with Goodwin Procter in connection with acquisition

August 23, 2023 M&A

Leading global private equity firms TA Associates and Warburg Pincus LLC have entered into an agreement to acquire a majority stake in Epassi Group from majority shareholder Bregal Milestone. Vinge acted as counsel to TA Associates with respect to Swedish matters in the transaction. Vinge advised TA Associates alongside Goodwin Procter.

Leading global private equity firms TA Associates and Warburg Pincus LLC have entered into an agreement to acquire a majority stake in Epassi Group from majority shareholder Bregal Milestone. Vinge acted as counsel to TA Associates with respect to Swedish matters in the transaction. Vinge advised TA Associates alongside Goodwin Procter.

TA is a leading global private equity firm focused on scaling growth in profitable companies. Warburg Pincus is a leading global growth investor and an experienced partner to management teams seeking to build durable companies with sustainable value. Epassi Group is Europe’s leading digital solution for employee benefits, with a reach of nearly 13 million users, over 13 500 employers, and more than 59 000 service providers. Epassi is a market leader in the provision of digital employee benefits within the Nordics, Italy and the UK and has been awarded by the Financial Times as one of the fastest growing companies in Europe in 2022 and 2023.

Vinge's team consisted mainly of Sofie Nordgren, Niklas Törnell and Emil Sandgrim.

Full pressrelease 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025